India Vaccine Market Analysis, Size, Share & Growth | 2034

The India vaccine market was valued at INR 118.76 billion in 2024, driven by the high burden of infectious diseases, rising strategic collaborations, and increased focus on local vaccine production capabilities in the country. The market is expected to grow at a CAGR of 8.8% during the forecast period of 2025-2034, with the values likely to reach INR 278.53 billion by 2034.

Get a Free Sample Report with a Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market/requestsample

Market Overview

The vaccine market in India has evolved into a robust industry due to increasing demand for immunisation programs, government support, and a growing emphasis on research and development (R&D). India is one of the largest vaccine producers globally, supplying vaccines to over 150 countries. The country’s vaccine industry is characterised by a diverse portfolio that includes vaccines for diseases like polio, hepatitis, tuberculosis, influenza, and COVID-19.

Strategic partnerships between global pharmaceutical companies and local manufacturers have further strengthened the industry’s growth. Additionally, the development of cost-effective vaccines and the adoption of advanced technologies are paving the way for innovation and expansion in the Indian vaccine market.

Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market

Market Dynamics

Drivers

1. High Burden of Infectious Diseases: The prevalence of diseases such as measles, tuberculosis, and hepatitis drives the demand for vaccines.
2. Strong Government Initiatives: Programs like Mission Indradhanush and Universal Immunisation Programme (UIP) are expanding vaccination coverage.
3. Local Production Capabilities: India’s expertise in mass vaccine production ensures affordability and accessibility.
4. Rising Awareness: Increasing awareness about immunisation benefits fuels vaccine uptake.
5. Strategic Collaborations: Partnerships between global and local players enhance R&D and distribution networks.

Restraints

1. Regulatory Challenges: Stringent approval processes for vaccines can delay market entry.
2. Cold Chain Logistics: Maintaining cold chain infrastructure remains a challenge, especially in rural areas.
3. Vaccine Hesitancy: Misinformation and cultural beliefs hinder vaccine adoption in some regions.

Opportunities

1. Focus on Pandemic Preparedness: The COVID-19 pandemic has highlighted the need for robust vaccine development capabilities.
2. Expansion of Adult Vaccination Programs: Increasing focus on adult immunisation for diseases like influenza and HPV presents growth opportunities.
3. Emerging Technologies: mRNA and vector-based vaccines offer potential for innovative solutions.

Challenges

1. Unequal Distribution: Urban-rural disparities in vaccine access remain a critical issue.
2. High R&D Costs: Developing vaccines for emerging diseases requires significant investment.

External Market Trends

1. Rise of Combination Vaccines: Combination vaccines reduce the number of injections and improve compliance.
2. Integration of Digital Platforms: Digital tools are being used for vaccine tracking and awareness campaigns.
3. Increased Focus on Preventive Healthcare: A growing emphasis on prevention rather than treatment is driving vaccine adoption.
4. Export Growth: India’s role as a major vaccine exporter continues to expand.

Market Segmentation

By Vaccine Type

1. Preventive Vaccines: Used to prevent diseases before they occur, including vaccines for polio, measles, and hepatitis.
   
2. Therapeutic Vaccines: Target chronic conditions such as cancer and autoimmune diseases.

By Technology

1. Inactivated Vaccines: Contain killed pathogens, widely used for diseases like influenza and rabies.
2. Live Attenuated Vaccines: Use weakened pathogens, effective for diseases like measles and yellow fever.
3. Subunit and Conjugate Vaccines: Use parts of pathogens, known for safety and efficacy.
4. mRNA Vaccines: A newer technology, gaining prominence post-COVID-19.

By End-User

1. Paediatric Segment: Vaccines for children, accounting for a significant share of the market.
2. Adult Segment: Growing demand for vaccines targeting diseases like influenza and HPV in adults.

By Distribution Channel

1. Government Channels: Major distribution network through national immunisation programs.
2. Private Healthcare Providers: Increasing role in urban and semi-urban areas.
3. Online Platforms: Emerging as a convenient option for vaccine bookings and awareness.

Market Growth

The India vaccine market is poised for significant growth due to increased immunisation coverage, advancements in technology, and the development of indigenous vaccines. Key growth regions include urban centres like Delhi, Mumbai, and Bangalore, alongside rural areas supported by government outreach programs.

Recent Market Developments

1. Serum Institute of India: Expanded its vaccine portfolio with new launches targeting both domestic and international markets.
   
2. Bharat Biotech: Collaborated with global partners to develop next-generation vaccines for emerging diseases.
   
3. Zydus Cadila: Introduced India’s first DNA-based COVID-19 vaccine, marking a milestone in vaccine innovation.

Key Players

1. Serum Institute of India

The world’s largest vaccine manufacturer by volume, Serum Institute produces affordable and high-quality vaccines for global distribution.

2. Bharat Biotech

Known for its innovation, Bharat Biotech has developed vaccines for diseases such as rotavirus, rabies, and COVID-19.

3. Zydus Cadila

A leading player in vaccine R&D, Zydus Cadila focuses on developing novel vaccines, including DNA-based technologies.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the India vaccine market, accelerating vaccine R&D and production capabilities. India emerged as a global hub for COVID-19 vaccines, supplying billions of doses domestically and internationally. The pandemic also highlighted the importance of vaccine equity and strengthened the focus on pandemic preparedness.

FAQs

1. What drives the India vaccine market?
The market is driven by the high burden of infectious diseases, government immunisation programs, and advancements in local vaccine production.

2. Which vaccine types dominate the market?
Preventive vaccines account for the largest share, targeting diseases like polio, measles, and hepatitis.

3. How has COVID-19 influenced the market?
The pandemic accelerated vaccine development and positioned India as a global leader in vaccine production and distribution.

4. What are the major challenges in the vaccine market?
Challenges include cold chain logistics, vaccine hesitancy, and regulatory hurdles.

5. Who are the key players in the India vaccine market?
Serum Institute of India, Bharat Biotech, and Zydus Cadila are the leading players.